Innate Immunotherapeutics completes IPO

Innate Immunotherapeutics Ltd. (ASX:IIL), Auckland, New Zealand Business: Autoimmune, Cancer, Infectious Date completed: 12/17/13 Type: IPO Raised: A$10 million ($9 million) Shares: 50 million Price: ...